CXCR5 and benign prostatic hyperplasia: As previously mentioned, the addition of rHuCXCL13 could promote the transition from the G0/G1 phase to the G2/M phase, enhance cell proliferation and facilitate the EMT process in BPH-1 cells, while the addition of anti-CXCR5 partially blocked these processes (Figure 5).